| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Correction to Lancet Diabetes Endocrinol 2016; 4: 19
|
|
|
2016
|
4 |
2 |
p. e2-
1 p.
|
artikel
|
| 2 |
Correction to Lancet Diabetes Endocrinol 2015; 3: 928–29
|
|
|
2016
|
4 |
2 |
p. e2-
1 p.
|
artikel
|
| 3 |
Correction to Lancet Diabetes Endocrinol 2015; published online Nov 24. http://dx.doi.org/10.1016/S2213-8587(15)00457-X
|
|
|
2016
|
4 |
2 |
p. e2-
1 p.
|
artikel
|
| 4 |
Country in Focus: diabetes epidemic poses challenge for health care in India
|
Bagcchi, Sanjeet
|
|
2016
|
4 |
2 |
p. 101-102
2 p.
|
artikel
|
| 5 |
Diabetes and infection: assessing the association with glycaemic control in population-based studies
|
Pearson-Stuttard, Jonathan
|
|
2016
|
4 |
2 |
p. 148-158
11 p.
|
artikel
|
| 6 |
Diabetes-related metabolic risk factors in internal migrant workers in China: a national surveillance study
|
Bi, Yufang
|
|
2016
|
4 |
2 |
p. 125-135
11 p.
|
artikel
|
| 7 |
Dr Mike: Sharing health leads to better health
|
Morgan, Jules
|
|
2016
|
4 |
2 |
p. 103-
1 p.
|
artikel
|
| 8 |
Early-onset type 2 diabetes: high lifetime risk for cardiovascular disease
|
Song, Soon H
|
|
2016
|
4 |
2 |
p. 87-88
2 p.
|
artikel
|
| 9 |
Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial
|
Brown, Morris J
|
|
2016
|
4 |
2 |
p. 136-147
12 p.
|
artikel
|
| 10 |
Gradual reduction of sugar in soft drinks without substitution as a strategy to reduce overweight, obesity, and type 2 diabetes: a modelling study
|
Ma, Yuan
|
|
2016
|
4 |
2 |
p. 105-114
10 p.
|
artikel
|
| 11 |
Health and lifestyle changes among migrant workers in China: implications for the healthy migrant effect
|
Salazar, Miguel A
|
|
2016
|
4 |
2 |
p. 89-90
2 p.
|
artikel
|
| 12 |
INDEPTH Network: contributing to the data revolution
|
Ekström, Anna Mia
|
|
2016
|
4 |
2 |
p. 97-
1 p.
|
artikel
|
| 13 |
Insulin patents and market exclusivities: unresolved issues
|
Kaplan, Warren
|
|
2016
|
4 |
2 |
p. 98-
1 p.
|
artikel
|
| 14 |
Insulin patents and market exclusivities: unresolved issues – Authors' reply
|
Luo, Jing
|
|
2016
|
4 |
2 |
p. 98-99
2 p.
|
artikel
|
| 15 |
Marketing obesity
|
Burki, Talha Khan
|
|
2016
|
4 |
2 |
p. 104-
1 p.
|
artikel
|
| 16 |
Preventing new-onset diabetes in thiazide-treated patients
|
Mancia, Giuseppe
|
|
2016
|
4 |
2 |
p. 90-92
3 p.
|
artikel
|
| 17 |
Research in brief
|
Kang, Seema
|
|
2016
|
4 |
2 |
p. 100-
1 p.
|
artikel
|
| 18 |
Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: a cross-sectional study
|
Huo, Xiaoxu
|
|
2016
|
4 |
2 |
p. 115-124
10 p.
|
artikel
|
| 19 |
Sugar: a shove to industry rather than a nudge to consumers?
|
Lobstein, Tim
|
|
2016
|
4 |
2 |
p. 86-87
2 p.
|
artikel
|
| 20 |
Sugar: pushing forward on cutting back
|
The Lancet Diabetes & Endocrinology,
|
|
2016
|
4 |
2 |
p. 85-
1 p.
|
artikel
|
| 21 |
Sweetening of the global diet, particularly beverages: patterns, trends, and policy responses
|
Popkin, Barry M
|
|
2016
|
4 |
2 |
p. 174-186
13 p.
|
artikel
|
| 22 |
Taking action on sugar
|
James, W Philip T
|
|
2016
|
4 |
2 |
p. 92-94
3 p.
|
artikel
|
| 23 |
The rollercoaster of post-bariatric hypoglycaemia
|
Patti, Mary-Elizabeth
|
|
2016
|
4 |
2 |
p. 94-96
3 p.
|
artikel
|
| 24 |
Type 2 diabetes and the skeleton: new insights into sweet bones
|
Shanbhogue, Vikram V
|
|
2016
|
4 |
2 |
p. 159-173
15 p.
|
artikel
|
Tijdschrift beschrijving